Global Brain Mapping Instruments Market
Global Brain Mapping Instruments Market

Brain Mapping Instruments Comprehensive Study by Type (Computed Tomography, Positron Emission Tomography, Electroencephalography, Magnetoencephalography, Other), Application (Hospitals, Neurological Centers and Research Institutions, Ambulatory Surgical Centers (ASCs) and Clinics, Diagnostic Centers, Other End Users) Players and Region - Global Market Outlook to 2024

Brain Mapping Instruments Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Aug 2019 Edition 212 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Brain mapping is a technique used to study the structure and functions of different regions of the brain and refers to a recording of brain wave activities. It helps surgeons in identifying brain areas responsible for critical functions of the body such as movement, vision, sensation, and speech. The key driving forces of the brain mapping instruments market in emerging economies are rising government initiatives and rising awareness regarding effective healthcare systems.

The market study is being classified by Type (Computed Tomography, Positron Emission Tomography, Electroencephalography, Magnetoencephalography and Other), by Application (Hospitals, Neurological Centers and Research Institutions, Ambulatory Surgical Centers (ASCs) and Clinics, Diagnostic Centers and Other End Users) and major geographies with country level break-up.

GE Healthcare (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthcare (Germany), Natus Medical (United States), Covidien (Ireland), Nihon Kohden (Japan), Advanced Brain Monitoring (United States), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (United States), Medtronic plc (Ireland) and CAS Medical Systems, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Electrical Geodesics Incorporated (United States), Medtronic plc (Ireland) and CAS Medical Systems, Inc. (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Brain Mapping Instruments market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Brain Mapping Instruments market by Type, Application and Region.

On the basis of geography, the market of Brain Mapping Instruments has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Drivers
  • Increasing Incidence and Prevalence of Neurological Disorders
  • Rising Awareness of Neurodegenerative Disorders

Market Trend
  • Technological Advancements in Brain Mapping Instruments
  • Growing Incidence of Traumatic Brain Injuries

Restraints
  • High Cost of Complex Brain Mapping Instruments
  • Unfavourable Reimbursement Policies

Opportunities
  • Increasing Demand for Noninvasive and Minimally Invasive Devices
  • Surging Application in Clinical Trials

Challenges
  • Lack of Trained Professionals
  • Stringent Regulatory Guidelines





Key Target Audience
Brain Mapping Instruments and Accessories Manufacturers, Healthcare Institutions (Hospitals and Outpatient Clinics), Distributors and Suppliers Brain Mapping Instruments, Diagnostic Centers, Neurological Centers, Health Centers/Clinics, End Users and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Computed Tomography
  • Positron Emission Tomography
  • Electroencephalography
  • Magnetoencephalography
  • Other
By Application
  • Hospitals
  • Neurological Centers and Research Institutions
  • Ambulatory Surgical Centers (ASCs) and Clinics
  • Diagnostic Centers
  • Other End Users
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence and Prevalence of Neurological Disorders
      • 3.2.2. Rising Awareness of Neurodegenerative Disorders
    • 3.3. Market Challenges
      • 3.3.1. Lack of Trained Professionals
      • 3.3.2. Stringent Regulatory Guidelines
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Brain Mapping Instruments
      • 3.4.2. Growing Incidence of Traumatic Brain Injuries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Brain Mapping Instruments, by Type, Application and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Brain Mapping Instruments (Value)
      • 5.2.1. Global Brain Mapping Instruments by: Type (Value)
        • 5.2.1.1. Computed Tomography
        • 5.2.1.2. Positron Emission Tomography
        • 5.2.1.3. Electroencephalography
        • 5.2.1.4. Magnetoencephalography
        • 5.2.1.5. Other
      • 5.2.2. Global Brain Mapping Instruments by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Neurological Centers and Research Institutions
        • 5.2.2.3. Ambulatory Surgical Centers (ASCs) and Clinics
        • 5.2.2.4. Diagnostic Centers
        • 5.2.2.5. Other End Users
      • 5.2.3. Global Brain Mapping Instruments Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Brain Mapping Instruments (Volume)
      • 5.3.1. Global Brain Mapping Instruments by: Type (Volume)
        • 5.3.1.1. Computed Tomography
        • 5.3.1.2. Positron Emission Tomography
        • 5.3.1.3. Electroencephalography
        • 5.3.1.4. Magnetoencephalography
        • 5.3.1.5. Other
      • 5.3.2. Global Brain Mapping Instruments by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Neurological Centers and Research Institutions
        • 5.3.2.3. Ambulatory Surgical Centers (ASCs) and Clinics
        • 5.3.2.4. Diagnostic Centers
        • 5.3.2.5. Other End Users
      • 5.3.3. Global Brain Mapping Instruments Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Brain Mapping Instruments (Price)
      • 5.4.1. Global Brain Mapping Instruments by: Type (Price)
  • 6. Brain Mapping Instruments: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GE Healthcare (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Koninklijke Philips N.V. (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens Healthcare (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Natus Medical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Covidien (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nihon Kohden (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Advanced Brain Monitoring (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Compumedics Ltd. (Australia)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Electrical Geodesics Incorporated (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Medtronic plc (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. CAS Medical Systems, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Brain Mapping Instruments Sale, by Type, Application and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Brain Mapping Instruments (Value)
      • 7.2.1. Global Brain Mapping Instruments by: Type (Value)
        • 7.2.1.1. Computed Tomography
        • 7.2.1.2. Positron Emission Tomography
        • 7.2.1.3. Electroencephalography
        • 7.2.1.4. Magnetoencephalography
        • 7.2.1.5. Other
      • 7.2.2. Global Brain Mapping Instruments by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Neurological Centers and Research Institutions
        • 7.2.2.3. Ambulatory Surgical Centers (ASCs) and Clinics
        • 7.2.2.4. Diagnostic Centers
        • 7.2.2.5. Other End Users
      • 7.2.3. Global Brain Mapping Instruments Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Brain Mapping Instruments (Volume)
      • 7.3.1. Global Brain Mapping Instruments by: Type (Volume)
        • 7.3.1.1. Computed Tomography
        • 7.3.1.2. Positron Emission Tomography
        • 7.3.1.3. Electroencephalography
        • 7.3.1.4. Magnetoencephalography
        • 7.3.1.5. Other
      • 7.3.2. Global Brain Mapping Instruments by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Neurological Centers and Research Institutions
        • 7.3.2.3. Ambulatory Surgical Centers (ASCs) and Clinics
        • 7.3.2.4. Diagnostic Centers
        • 7.3.2.5. Other End Users
      • 7.3.3. Global Brain Mapping Instruments Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Brain Mapping Instruments (Price)
      • 7.4.1. Global Brain Mapping Instruments by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Brain Mapping Instruments: by Type(USD Million)
  • Table 2. Brain Mapping Instruments Computed Tomography , by Region USD Million (2013-2018)
  • Table 3. Brain Mapping Instruments Positron Emission Tomography , by Region USD Million (2013-2018)
  • Table 4. Brain Mapping Instruments Electroencephalography , by Region USD Million (2013-2018)
  • Table 5. Brain Mapping Instruments Magnetoencephalography , by Region USD Million (2013-2018)
  • Table 6. Brain Mapping Instruments Other , by Region USD Million (2013-2018)
  • Table 7. Brain Mapping Instruments: by Application(USD Million)
  • Table 8. Brain Mapping Instruments Hospitals , by Region USD Million (2013-2018)
  • Table 9. Brain Mapping Instruments Neurological Centers and Research Institutions , by Region USD Million (2013-2018)
  • Table 10. Brain Mapping Instruments Ambulatory Surgical Centers (ASCs) and Clinics , by Region USD Million (2013-2018)
  • Table 11. Brain Mapping Instruments Diagnostic Centers , by Region USD Million (2013-2018)
  • Table 12. Brain Mapping Instruments Other End Users , by Region USD Million (2013-2018)
  • Table 13. South America Brain Mapping Instruments, by Country USD Million (2013-2018)
  • Table 14. South America Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 15. South America Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 16. Brazil Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 17. Brazil Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 18. Argentina Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 19. Argentina Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 20. Rest of South America Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 21. Rest of South America Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 22. Asia Pacific Brain Mapping Instruments, by Country USD Million (2013-2018)
  • Table 23. Asia Pacific Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 24. Asia Pacific Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 25. China Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 26. China Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 27. Japan Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 28. Japan Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 29. India Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 30. India Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 31. South Korea Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 32. South Korea Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 33. Taiwan Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 34. Taiwan Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 35. Australia Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 36. Australia Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 37. Rest of Asia-Pacific Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 38. Rest of Asia-Pacific Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 39. Europe Brain Mapping Instruments, by Country USD Million (2013-2018)
  • Table 40. Europe Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 41. Europe Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 42. Germany Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 43. Germany Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 44. France Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 45. France Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 46. Italy Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 47. Italy Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 48. United Kingdom Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 49. United Kingdom Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 50. Netherlands Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 51. Netherlands Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 52. Rest of Europe Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 53. Rest of Europe Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 54. MEA Brain Mapping Instruments, by Country USD Million (2013-2018)
  • Table 55. MEA Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 56. MEA Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 57. Middle East Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 58. Middle East Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 59. Africa Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 60. Africa Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 61. North America Brain Mapping Instruments, by Country USD Million (2013-2018)
  • Table 62. North America Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 63. North America Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 64. United States Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 65. United States Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 66. Canada Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 67. Canada Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 68. Mexico Brain Mapping Instruments, by Type USD Million (2013-2018)
  • Table 69. Mexico Brain Mapping Instruments, by Application USD Million (2013-2018)
  • Table 70. Brain Mapping Instruments Sales: by Type(K Unit)
  • Table 71. Brain Mapping Instruments Sales Computed Tomography , by Region K Unit (2013-2018)
  • Table 72. Brain Mapping Instruments Sales Positron Emission Tomography , by Region K Unit (2013-2018)
  • Table 73. Brain Mapping Instruments Sales Electroencephalography , by Region K Unit (2013-2018)
  • Table 74. Brain Mapping Instruments Sales Magnetoencephalography , by Region K Unit (2013-2018)
  • Table 75. Brain Mapping Instruments Sales Other , by Region K Unit (2013-2018)
  • Table 76. Brain Mapping Instruments Sales: by Application(K Unit)
  • Table 77. Brain Mapping Instruments Sales Hospitals , by Region K Unit (2013-2018)
  • Table 78. Brain Mapping Instruments Sales Neurological Centers and Research Institutions , by Region K Unit (2013-2018)
  • Table 79. Brain Mapping Instruments Sales Ambulatory Surgical Centers (ASCs) and Clinics , by Region K Unit (2013-2018)
  • Table 80. Brain Mapping Instruments Sales Diagnostic Centers , by Region K Unit (2013-2018)
  • Table 81. Brain Mapping Instruments Sales Other End Users , by Region K Unit (2013-2018)
  • Table 82. South America Brain Mapping Instruments Sales, by Country K Unit (2013-2018)
  • Table 83. South America Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 84. South America Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 85. Brazil Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 86. Brazil Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 87. Argentina Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 88. Argentina Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 89. Rest of South America Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 90. Rest of South America Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 91. Asia Pacific Brain Mapping Instruments Sales, by Country K Unit (2013-2018)
  • Table 92. Asia Pacific Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 93. Asia Pacific Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 94. China Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 95. China Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 96. Japan Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 97. Japan Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 98. India Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 99. India Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 100. South Korea Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 101. South Korea Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 102. Taiwan Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 103. Taiwan Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 104. Australia Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 105. Australia Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 106. Rest of Asia-Pacific Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 107. Rest of Asia-Pacific Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 108. Europe Brain Mapping Instruments Sales, by Country K Unit (2013-2018)
  • Table 109. Europe Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 110. Europe Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 111. Germany Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 112. Germany Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 113. France Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 114. France Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 115. Italy Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 116. Italy Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 117. United Kingdom Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 118. United Kingdom Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 119. Netherlands Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 120. Netherlands Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 121. Rest of Europe Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 122. Rest of Europe Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 123. MEA Brain Mapping Instruments Sales, by Country K Unit (2013-2018)
  • Table 124. MEA Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 125. MEA Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 126. Middle East Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 127. Middle East Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 128. Africa Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 129. Africa Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 130. North America Brain Mapping Instruments Sales, by Country K Unit (2013-2018)
  • Table 131. North America Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 132. North America Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 133. United States Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 134. United States Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 135. Canada Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 136. Canada Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 137. Mexico Brain Mapping Instruments Sales, by Type K Unit (2013-2018)
  • Table 138. Mexico Brain Mapping Instruments Sales, by Application K Unit (2013-2018)
  • Table 139. Brain Mapping Instruments: by Type(USD/Units)
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Brain Mapping Instruments: by Type(USD Million)
  • Table 152. Brain Mapping Instruments Computed Tomography , by Region USD Million (2019-2024)
  • Table 153. Brain Mapping Instruments Positron Emission Tomography , by Region USD Million (2019-2024)
  • Table 154. Brain Mapping Instruments Electroencephalography , by Region USD Million (2019-2024)
  • Table 155. Brain Mapping Instruments Magnetoencephalography , by Region USD Million (2019-2024)
  • Table 156. Brain Mapping Instruments Other , by Region USD Million (2019-2024)
  • Table 157. Brain Mapping Instruments: by Application(USD Million)
  • Table 158. Brain Mapping Instruments Hospitals , by Region USD Million (2019-2024)
  • Table 159. Brain Mapping Instruments Neurological Centers and Research Institutions , by Region USD Million (2019-2024)
  • Table 160. Brain Mapping Instruments Ambulatory Surgical Centers (ASCs) and Clinics , by Region USD Million (2019-2024)
  • Table 161. Brain Mapping Instruments Diagnostic Centers , by Region USD Million (2019-2024)
  • Table 162. Brain Mapping Instruments Other End Users , by Region USD Million (2019-2024)
  • Table 163. South America Brain Mapping Instruments, by Country USD Million (2019-2024)
  • Table 164. South America Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 165. South America Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 166. Brazil Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 167. Brazil Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 168. Argentina Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 169. Argentina Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 170. Rest of South America Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 171. Rest of South America Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 172. Asia Pacific Brain Mapping Instruments, by Country USD Million (2019-2024)
  • Table 173. Asia Pacific Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 174. Asia Pacific Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 175. China Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 176. China Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 177. Japan Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 178. Japan Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 179. India Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 180. India Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 181. South Korea Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 182. South Korea Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 183. Taiwan Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 184. Taiwan Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 185. Australia Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 186. Australia Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 187. Rest of Asia-Pacific Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 188. Rest of Asia-Pacific Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 189. Europe Brain Mapping Instruments, by Country USD Million (2019-2024)
  • Table 190. Europe Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 191. Europe Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 192. Germany Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 193. Germany Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 194. France Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 195. France Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 196. Italy Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 197. Italy Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 198. United Kingdom Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 199. United Kingdom Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 200. Netherlands Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 201. Netherlands Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 202. Rest of Europe Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 203. Rest of Europe Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 204. MEA Brain Mapping Instruments, by Country USD Million (2019-2024)
  • Table 205. MEA Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 206. MEA Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 207. Middle East Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 208. Middle East Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 209. Africa Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 210. Africa Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 211. North America Brain Mapping Instruments, by Country USD Million (2019-2024)
  • Table 212. North America Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 213. North America Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 214. United States Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 215. United States Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 216. Canada Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 217. Canada Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 218. Mexico Brain Mapping Instruments, by Type USD Million (2019-2024)
  • Table 219. Mexico Brain Mapping Instruments, by Application USD Million (2019-2024)
  • Table 220. Brain Mapping Instruments Sales: by Type(K Unit)
  • Table 221. Brain Mapping Instruments Sales Computed Tomography , by Region K Unit (2019-2024)
  • Table 222. Brain Mapping Instruments Sales Positron Emission Tomography , by Region K Unit (2019-2024)
  • Table 223. Brain Mapping Instruments Sales Electroencephalography , by Region K Unit (2019-2024)
  • Table 224. Brain Mapping Instruments Sales Magnetoencephalography , by Region K Unit (2019-2024)
  • Table 225. Brain Mapping Instruments Sales Other , by Region K Unit (2019-2024)
  • Table 226. Brain Mapping Instruments Sales: by Application(K Unit)
  • Table 227. Brain Mapping Instruments Sales Hospitals , by Region K Unit (2019-2024)
  • Table 228. Brain Mapping Instruments Sales Neurological Centers and Research Institutions , by Region K Unit (2019-2024)
  • Table 229. Brain Mapping Instruments Sales Ambulatory Surgical Centers (ASCs) and Clinics , by Region K Unit (2019-2024)
  • Table 230. Brain Mapping Instruments Sales Diagnostic Centers , by Region K Unit (2019-2024)
  • Table 231. Brain Mapping Instruments Sales Other End Users , by Region K Unit (2019-2024)
  • Table 232. South America Brain Mapping Instruments Sales, by Country K Unit (2019-2024)
  • Table 233. South America Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 234. South America Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 235. Brazil Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 236. Brazil Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 237. Argentina Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 238. Argentina Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 239. Rest of South America Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 240. Rest of South America Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 241. Asia Pacific Brain Mapping Instruments Sales, by Country K Unit (2019-2024)
  • Table 242. Asia Pacific Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 243. Asia Pacific Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 244. China Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 245. China Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 246. Japan Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 247. Japan Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 248. India Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 249. India Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 250. South Korea Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 251. South Korea Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 252. Taiwan Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 253. Taiwan Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 254. Australia Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 255. Australia Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 256. Rest of Asia-Pacific Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 257. Rest of Asia-Pacific Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 258. Europe Brain Mapping Instruments Sales, by Country K Unit (2019-2024)
  • Table 259. Europe Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 260. Europe Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 261. Germany Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 262. Germany Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 263. France Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 264. France Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 265. Italy Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 266. Italy Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 267. United Kingdom Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 268. United Kingdom Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 269. Netherlands Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 270. Netherlands Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 271. Rest of Europe Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 272. Rest of Europe Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 273. MEA Brain Mapping Instruments Sales, by Country K Unit (2019-2024)
  • Table 274. MEA Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 275. MEA Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 276. Middle East Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 277. Middle East Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 278. Africa Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 279. Africa Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 280. North America Brain Mapping Instruments Sales, by Country K Unit (2019-2024)
  • Table 281. North America Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 282. North America Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 283. United States Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 284. United States Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 285. Canada Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 286. Canada Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 287. Mexico Brain Mapping Instruments Sales, by Type K Unit (2019-2024)
  • Table 288. Mexico Brain Mapping Instruments Sales, by Application K Unit (2019-2024)
  • Table 289. Brain Mapping Instruments: by Type(USD/Units)
  • Table 290. Research Programs/Design for This Report
  • Table 291. Key Data Information from Secondary Sources
  • Table 292. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Brain Mapping Instruments: by Type USD Million (2013-2018)
  • Figure 5. Global Brain Mapping Instruments: by Application USD Million (2013-2018)
  • Figure 6. South America Brain Mapping Instruments Share (%), by Country
  • Figure 7. Asia Pacific Brain Mapping Instruments Share (%), by Country
  • Figure 8. Europe Brain Mapping Instruments Share (%), by Country
  • Figure 9. MEA Brain Mapping Instruments Share (%), by Country
  • Figure 10. North America Brain Mapping Instruments Share (%), by Country
  • Figure 11. Global Brain Mapping Instruments: by Type K Unit (2013-2018)
  • Figure 12. Global Brain Mapping Instruments: by Application K Unit (2013-2018)
  • Figure 13. South America Brain Mapping Instruments Share (%), by Country
  • Figure 14. Asia Pacific Brain Mapping Instruments Share (%), by Country
  • Figure 15. Europe Brain Mapping Instruments Share (%), by Country
  • Figure 16. MEA Brain Mapping Instruments Share (%), by Country
  • Figure 17. North America Brain Mapping Instruments Share (%), by Country
  • Figure 18. Global Brain Mapping Instruments: by Type USD/Units (2013-2018)
  • Figure 19. Global Brain Mapping Instruments share by Players 2018 (%)
  • Figure 20. Global Brain Mapping Instruments share by Players (Top 3) 2018(%)
  • Figure 21. Global Brain Mapping Instruments share by Players (Top 5) 2018(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 24. GE Healthcare (United States) Revenue: by Geography 2018
  • Figure 25. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2018
  • Figure 27. Siemens Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Siemens Healthcare (Germany) Revenue: by Geography 2018
  • Figure 29. Natus Medical (United States) Revenue, Net Income and Gross profit
  • Figure 30. Natus Medical (United States) Revenue: by Geography 2018
  • Figure 31. Covidien (Ireland) Revenue, Net Income and Gross profit
  • Figure 32. Covidien (Ireland) Revenue: by Geography 2018
  • Figure 33. Nihon Kohden (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Nihon Kohden (Japan) Revenue: by Geography 2018
  • Figure 35. Advanced Brain Monitoring (United States) Revenue, Net Income and Gross profit
  • Figure 36. Advanced Brain Monitoring (United States) Revenue: by Geography 2018
  • Figure 37. Compumedics Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 38. Compumedics Ltd. (Australia) Revenue: by Geography 2018
  • Figure 39. Electrical Geodesics Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 40. Electrical Geodesics Incorporated (United States) Revenue: by Geography 2018
  • Figure 41. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 42. Medtronic plc (Ireland) Revenue: by Geography 2018
  • Figure 43. CAS Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. CAS Medical Systems, Inc. (United States) Revenue: by Geography 2018
  • Figure 45. Global Brain Mapping Instruments: by Type USD Million (2019-2024)
  • Figure 46. Global Brain Mapping Instruments: by Application USD Million (2019-2024)
  • Figure 47. South America Brain Mapping Instruments Share (%), by Country
  • Figure 48. Asia Pacific Brain Mapping Instruments Share (%), by Country
  • Figure 49. Europe Brain Mapping Instruments Share (%), by Country
  • Figure 50. MEA Brain Mapping Instruments Share (%), by Country
  • Figure 51. North America Brain Mapping Instruments Share (%), by Country
  • Figure 52. Global Brain Mapping Instruments: by Type K Unit (2019-2024)
  • Figure 53. Global Brain Mapping Instruments: by Application K Unit (2019-2024)
  • Figure 54. South America Brain Mapping Instruments Share (%), by Country
  • Figure 55. Asia Pacific Brain Mapping Instruments Share (%), by Country
  • Figure 56. Europe Brain Mapping Instruments Share (%), by Country
  • Figure 57. MEA Brain Mapping Instruments Share (%), by Country
  • Figure 58. North America Brain Mapping Instruments Share (%), by Country
  • Figure 59. Global Brain Mapping Instruments: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • GE Healthcare (United States)
  • Koninklijke Philips N.V. (Netherlands)
  • Siemens Healthcare (Germany)
  • Natus Medical (United States)
  • Covidien (Ireland)
  • Nihon Kohden (Japan)
  • Advanced Brain Monitoring (United States)
  • Compumedics Ltd. (Australia)
  • Electrical Geodesics Incorporated (United States)
  • Medtronic plc (Ireland)
  • CAS Medical Systems, Inc. (United States)
Additional players considered in the study are as follows:
Electrical Geodesics Incorporated (United States) , Medtronic plc (Ireland) , CAS Medical Systems, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation